Department of Human Development and Quantitative Methodology, University of Maryland, College Park.
Department of Psychology, University of Texas at Dallas, Richardson.
JAMA Psychiatry. 2022 Dec 1;79(12):1199-1208. doi: 10.1001/jamapsychiatry.2022.3483.
The early childhood temperament of behavioral inhibition (BI), characterized by inhibited and fearful behaviors, has been associated with heightened risk for anxiety and depression across the lifespan. Although several neurocognitive correlates underlying vulnerability to the development of anxiety among inhibited children have been identified, little is known about the neurocognitive correlates underlying vulnerability to the development of depression.
To examine whether blunted striatal activation to reward anticipation, a well-documented neurocognitive vulnerability marker of depression, moderates the association between early BI and the developmental changes in depression and anxiety from adolescence to adulthood.
DESIGN, SETTING, AND PARTICIPANTS: Participants in this prospective longitudinal study were recruited at age 4 months between 1989 and 1993 in the US. Follow-up assessments extended into 2018 (age 26 years). Data were analyzed between September 2021 to March 2022.
BI was measured through an observation paradigm in infancy (ages 14 and 24 months). Neural activity to anticipated rewards during a monetary incentive delay task was measured using functional magnetic resonance imaging in adolescence (between ages 15-18 years; 83 individuals had usable data). Anxiety and depressive symptoms were self-reported across adolescence to young adulthood (ages 15 and 26 years; n = 108). A latent change score model, accounting for the interdependence between anxiety and depression, tested the moderating role of striatal activity to reward anticipation in the association between early BI and changes in anxiety and depressive symptoms. A region of interest approach limited statistical tests to regions within the striatum (ie, nucleus accumbens, caudate head, caudate body, putamen).
Of 165 participants, 84 (50.1%) were female and 162 (98%) were White. Preliminary analyses revealed significant increases in anxiety and depressive symptoms across ages 15 to 26 years, as well as individual variation in the magnitude of changes. Main analyses showed that reduced activity in the nucleus accumbens to reward anticipation moderated the association between early BI and increases in depressive (β = -0.32; b = -4.23; 95% CI, -7.70 to -0.76; P = .02), and more depressive symptoms at age 26 years (β = -0.47; b = -5.09; 95% CI, -7.74 to -2.43; P < .001). However, there were no significant interactions associated with latent changes in anxiety across age nor anxiety at age 26 years. Activity in the caudate and putamen did not moderate these associations.
Blunted reward sensitivity in the ventral striatum may be a developmental risk factor connecting an inhibited childhood temperament and depression over the transition to adulthood. Future studies should examine the efficacy of prevention programs, which target maladaptive reward processing and motivational deficits among anxious youths, in reducing risks for later depression.
以行为抑制(BI)为特征的儿童早期气质,表现为抑制和恐惧行为,与整个生命周期的焦虑和抑郁风险增加有关。尽管已经确定了几个神经认知相关性,这些相关性是易患抑制儿童焦虑发展的基础,但对于易患抑郁发展的神经认知相关性知之甚少。
研究在奖励预期中的纹状体激活迟钝,这是抑郁的一个有据可查的神经认知易损性标志物,是否可以调节早期 BI 与从青春期到成年期抑郁和焦虑发展变化之间的关联。
设计、地点和参与者:本前瞻性纵向研究的参与者于 1989 年至 1993 年间在美国招募,年龄为 4 个月。随访评估持续到 2018 年(26 岁)。数据分析于 2021 年 9 月至 2022 年 3 月之间进行。
在婴儿期(14 和 24 个月)通过观察范式测量 BI。在青少年时期(15-18 岁之间;83 人有可用数据)使用功能磁共振成像测量对预期奖励的神经活动。在青少年到成年早期(15 和 26 岁;n=108)通过自我报告焦虑和抑郁症状。一个潜在的变化分数模型,考虑到焦虑和抑郁之间的相互依存关系,测试了纹状体奖励预期中纹状体活动对早期 BI 与焦虑和抑郁症状变化之间关联的调节作用。感兴趣区域的方法将统计检验限制在纹状体内部的区域(即伏隔核、尾状核头部、尾状核体、壳核)。
在 165 名参与者中,84 名(50.1%)为女性,162 名(98%)为白人。初步分析显示,焦虑和抑郁症状在 15 岁至 26 岁之间显著增加,并且变化幅度存在个体差异。主要分析表明,奖励预期中伏隔核的活动减少调节了早期 BI 与抑郁(β=-0.32;b=-4.23;95%CI,-7.70 至-0.76;P=0.02)和 26 岁时更多的抑郁症状(β=-0.47;b=-5.09;95%CI,-7.74 至-2.43;P<0.001)之间的关联。然而,与焦虑的潜在变化或 26 岁时的焦虑都没有显著的相互作用。尾状核和壳核的活动没有调节这些关联。
腹侧纹状体的奖励敏感性降低可能是连接抑制性儿童气质和成年过渡期抑郁的发育风险因素。未来的研究应该检查针对焦虑青少年的适应性奖励处理和动机缺陷的预防计划的疗效,以降低后期抑郁的风险。